Kayıkçıoğlu, Erkan, and Arif Hakan Onder. 2022. “The Pan-Immune-Inflammation-Value Predicts the Survival of Patients With Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors”. Chronicles of Precision Medical Researchers 3 (3). https://doi.org/10.5281/zenodo.7195780.